Ultrasound vs. Nasofibroscopy for Evaluating Dysphagia After Extubation in the ICU
DISFEX
Comparison Between Ultrasonographic and Nasofibroscopic Evaluation in Extubated Patients With Dysphagia in the Intensive Care Unit.
2 other identifiers
interventional
40
1 country
1
Brief Summary
The goal of this observational study is to evaluate the diagnostic performance and concordance of bedside cervical ultrasonography compared to Fiberoptic Endoscopic Evaluation of Swallowing (FEES) for the early detection of post-extubation dysphagia in critically ill adult patients. The main questions it aims to answer are:
- What is the degree of diagnostic concordance (Kappa index) between cervical ultrasonography and nasofibroscopy (FEES) for detecting dysphagia in the Intensive Care Unit (ICU)?
- What are the sensitivity, specificity, and predictive values of ultrasonography as a non-invasive screening tool compared to the gold standard (FEES)?
- Are there specific cut-off points for ultrasonographic parameters (such as hyoid bone displacement and laryngeal elevation) that accurately identify patients at risk of aspiration? Methodology and Comparison: Researchers will evaluate a cohort of patients who have undergone mechanical ventilation for more than 48 hours. The study compares the findings of cervical ultrasonography (an accessible and non-invasive bedside method) with FEES (the clinical gold standard) to determine the feasibility of ultrasound as an initial screening tool in the ICU setting. Participant Tasks: Participants will undergo the following procedures within 24 to 48 hours post-extubation: A bedside cervical ultrasonography to measure swallowing-related anatomical movements, such as hyoid displacement and laryngeal elevation. A nasofibroscopy (FEES) performed by trained personnel to directly visualize the pharyngeal and laryngeal structures during swallowing. A clinical evaluation of cranial nerve function and monitoring for respiratory complications like bronchoaspiration or pneumonia.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jul 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 15, 2026
CompletedStudy Start
First participant enrolled
July 27, 2026
CompletedFirst Posted
Study publicly available on registry
July 29, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
August 31, 2026
ExpectedJuly 29, 2026
July 1, 2026
5 days
June 15, 2026
July 27, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Diagnostic Concordance (Kappa Index).
The degree of diagnostic agreement between bedside cervical ultrasonography and Fiberoptic Endoscopic Evaluation of Swallowing (FEES) for the detection of post-extubation dysphagia. This will be evaluated using Cohen's Kappa coefficient to determine if ultrasonography is a reliable alternative to the gold standard.
At 48 hours post-extubation.
Secondary Outcomes (3)
Diagnostic Sensitivity and Specificity.
At 48 hours post-extubation.
Ultrasonographic Parameter Cut-off Points.
At 48 hours post-extubation.
Incidence of Respiratory Complications.
From ICU admission through ICU discharge, up to 30 days
Study Arms (1)
Diagnostic Evaluation Group
EXPERIMENTALThis is a single-arm study where all participants who have been extubated after more than 48 hours of mechanical ventilation will undergo a sequential diagnostic assessment. Each participant will receive: * Cervical Ultrasonography: A non-invasive bedside evaluation to measure hyoid bone displacement and laryngeal elevation. * Fiberoptic Endoscopic Evaluation of Swallowing (FEES): The gold standard endoscopic procedure to visualize the pharyngeal and laryngeal phases of swallowing and detect penetration or aspiration.
Interventions
Measurement of anatomical swallowing-related structures (hyoid bone and larynx) using a convex or linear transducer at the patient's bedside.
Endoscopic visualization of the larynx and pharynx during the administration of various bolus consistencies to assess swallowing safety.
Eligibility Criteria
You may qualify if:
- Critically ill patients admitted to the Intensive Care Unit (ICU).
- Patients aged 18 years or older.
- Patients who have required orotracheal intubation and mechanical ventilation for a period exceeding 48 hours.
- Patients successfully liberated from mechanical ventilation (post-extubation phase).
- Obtainment of signed Informed Consent from the patient or their legal representative.
You may not qualify if:
- Patients with a known prior history of oropharyngeal dysphagia, esophageal disorders, or structural abnormalities of the upper airway.
- Patients with pre-existing neurological diseases that compromise the swallowing reflex (e.g., advanced Parkinson's disease, previous stroke with residual dysphagia, Amyotrophic Lateral Sclerosis).
- Patients with a history of head and neck surgery or radiotherapy.
- Patients with a Glasgow Coma Scale (GCS) score \< 13 at the time of evaluation.
- Patients with hemodynamic instability or severe respiratory distress that precludes the diagnostic procedures.
- Anatomical limitations that prevent the correct placement of the ultrasound transducer or the introduction of the nasofibroscope (e.g., severe facial trauma, nasal obstruction).
- Medical contraindication for Fiberoptic Endoscopic Evaluation of Swallowing (FEES).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hospital H+
Querétaro City, Querétaro, 7600, Mexico
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
June 15, 2026
First Posted
July 29, 2026
Study Start
July 27, 2026
Primary Completion
August 1, 2026
Study Completion (Estimated)
August 31, 2026
Last Updated
July 29, 2026
Record last verified: 2026-07